A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.

Olivier RascolRossella MedoriCorine BaayenPedro SuchDidier Meuliennull null

Published in: Movement disorders : official journal of the Movement Disorder Society (2022)

There was no evidence in this study that foliglurax has efficacy in improving levodopa-induced motor complications in PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

phase ii study
placebo controlled
double blind
open label

clinical trial
locally advanced
high glucose
parkinson disease

risk factors
deep brain stimulation
systematic review
drug induced

oxidative stress
rectal cancer
meta analyses
stress induced